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PENGENALPASTIAN KULAT DIPENCILKAN DARIPADA SISA 
KLINIKAL DAN PENYAHAKTIFAN SPORA KULAT DENGAN KARBON 
DIOKSIDA LAMPAU GENTING  
 
ABSTRAK 
Sisa klinikal dianggap sebagai sumber yang mendatangkan jangkitan kepada 
manusia disebabkan adanya mikroorganisma patogenik seperti bakteria, virus dan 
kulat. Untuk merawat bahan sisa klinikal, pembasmian kuman menggunakan bahan 
kimia dan pendedahan kepada sinaran rawatan sisa klinikal termasuk 
menginsinerasikan, biasa digunakan, namun kaedah ini tidak dapat membunuh  
patogen sepenuhnya.  Membakar menerusi insinerasi bukan teknologi yang sesuai 
untuk merawat sisa klinikal disebabkan oleh pengeluaran bahan pencemar berbahaya 
termasuk dioksin dan furan yang tidak dapat dielakkan. Kajian ini dijalankan dengan 
mengenal pasti dan menyahaktifkan spesies kulat yang terdapat di dalam sisa klinikal 
yang diperoleh daripada Pusat Kesihatan USM (kampus utama). Penyahaktifan 
patogen (spora) dijalankan dengan menggunakan teknologi alternatif termaju bukan 
termal menggunakankarbon dioksida lampau genting (SC-CO2) dalam rawatan sisa 
klinikal.  Satu ratus lima puluh pencilan kulat dikenalpasti daripada 92 sampel sisa 
klinikal yang dikulturkan di atas media yang kaya dengan bahan sayuran (V8A). 
Pencilan kulat telah dijalankan menggunakan teknik spora tunggal dan dikenal pasti 
melalui kaedah fenotip. Ciri morfologi spora kulat dijalankan dengan menggunakan 
kaedah imbasan mikroskop elektron. Dari analisis fenotip, pencilan kulat 
diklasifikasikan ke dalam 8 genera dan 36 spesies. Antara kesemua pencilan, 
Aspergillus spp. di dalam seksyen Nigri (10%), A. niger (9.3%), A. fumigatus (8.7%), 
 xix 
 
P. simplicissium (8%), A. tubingensis (7.3%), A. terreus var. terreus (6.6%), P. 
waksmanii (6%) and C. lunata (6%) merupakan yang banyak ditemui. Dari 
pemerhatian yang dijalankan di antara kelima bahagian Pusat Sejahtera, sisa klinikal 
yang didapati dari makmal dignostik di Bahagian hematologi menunjukkan bilangan 
spesies kulat yang paling tinggi (29 spesies). Sisa klinikal seperti sarung tangan 
terpakai mempunyai bilangan spesies kulat (19 spesies) yang paling tinggi di 
kalangan 17 jenis sisa klinikal yang disarikan. Antara kesemua spesies kulat, 
Aspergillus spp. mempamerkan kadar pertumbuhan yang lebih tinggi pada suhu 37˚C 
daripada 28˚C, dan ini menunjukkan keupayaan kulat oportunis untuk mengenakan 
penyakit pada manusia. Penyahaktifan spora kulat menggunakan SC-CO2 telah dikaji 
pada julat tekanan 30-40 MPa, suhu 35-75˚C dan masa 30-90 min dan nilai 
optimuma ditentukan dengan kaedah gerak balas permukaan (RSM). A. niger telah 
digunakan sebagai petunjuk biologi dengan kepekatan awal 6 log sebagaimana yang 
ditentukan dengan himotisometer dan teknik kultur (CFU g-1). Kecekapan SC-CO2 
dalam menyahaktifkan spora kulat ditentukan berdasarkan penurunan log dan 
peratusan penyahaktifan. Penyahaktifan optimum  diperolehi pada 35 MPa, 75 ˚C, 
dalam masa 90 min yang  menunjukkan penurunan log yang diramalkan berbanding 
dengan  yang dikaji adalah 5.93 dan 6 log masing-masing dengan 99,9999%  nilai 
peratus penyahaktifan.  Kulat yang telah dirawat dengan SC-CO2 juga tidak 
menunjukkan kesan boleh hidup kembali setelah dikulturkan semula ke atas media. 
Pada tahap optimum SC-CO2, spora kebanyakan spesies kulat yang paling biasa 
adalah dinyahaktifkan dengan sepenuhnya (6 pengurangan log). Penyahaktifan spora 
kulat dianalisakan di bawah mikroskop imbasan elektron, menunjukkan dengan 
rawatan SC-CO2, dinding sel kulat musnah jika dibandingkan dengan autoklaf stim 
dan tidak ada aktiviti enzim. Esei plat yang dikaji menunjukkan  bahawa spora kulat 
 xx 
 
yang telah dinyahaktifkan tidak menjanakan enzim luaran. Kesimpulan yang 
diperolehi adalah, bahan sisa klinikal mengandungi banyak kulat opportunis yang 
boleh menyebabkan beberapa penyakit di kalangan manusia. Kajian ini adalah 
signifikan dalam membuktikan penggunaan SC-CO2 sebagai kaedah termaju bukan 
termal mampu menyahaktifkan species kulat yang terdapat di dalam sisa klinikal 
lantas mengurangkan risiko kesihatan semasa pengendalian sisa klinikal yang 
menjadikan ianya lebih selamat.   
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IDENTIFICATION OF FUNGI ISOLATED FROM CLINICAL WASTES 
AND INACTIVATION OF FUNGAL SPORES BY USING SUPERCRITICAL 
CARBON DIOXIDE 
 
ABSTRACT 
Clinical wastes are considered as a serious infectious source to humans due to 
the existence pathogenic microorganism such as bacteria, virus and fungi. For the 
treatment of clinical wastes, chemical disinfection and irradiations methods including 
UV are commonly used, however, these treatment methods are unable to destroy 
pathogens completely. Incineration is not a suitable technology for the treatment of 
clinical wastes due to the inevitable production of hazardous pollutants (dioxins and 
furans).  The present study deals with the identification and inactivation of fungal 
species present in clinical waste samples collected from health care unit; the 
Wellness Centre of USM, Malaysia. The inactivation of the most common pathogens 
(fungal spore) were carried out using an advanced non-thermal alternative 
technology; supercritical carbon dioxide (SC-CO2) for safe handling of clinical 
wastes.  In this regards, 150 fungal isolates were identified from 92 clinical waste 
samples and cultured on V8A medium. The fungal isolates were purified using single 
spore technique and identified by phenotypic method. The morphological 
characterization of fungal spore were performed by using scanning electron 
microscope (SEM) analysis. On the basis of phenotypic analysis fungal isolates were 
classified in 8 genera and 36 species. Among all isolates, Aspergillus spp. in section 
Nigri (10%), A. niger (9.3%), A. fumigatus (8.7%), P. simplicissium (8%), A. 
tubingensis (7.3%), A. terreus var. terreus (6.6%), P. waksmanii (6%) and C. lunata 
(6%) were the most frequently found. It was also observed that among five sections 
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of the Wellness Centre, the clinical wastes collected from diagnostic labs of 
Haematology Section showed the highest numbers of fungal species (29). Glove 
wastes also demonstrated the highest number of fungal species (19) among seventeen 
types clinical wastes screened. Among all fungal species, Aspergillus spp. exhibited 
higher growth rate at 37˚C than at 28˚C, indicating the ability of these opportunistic 
fungi to cause diseases in human. The inactivation of fungal spores using SC-CO2 
was investigated at 30-40 MPa, 35-75 ˚C for a time period of 30-90 min and 
optimized by response surface methodology (RSM). A. niger was used as biological 
indicator with initial concentrations of 6 log as determined by haemocytometer 
counts and culture based technique. The efficiency of SC-CO2 in the inactivation of 
fungal spores was determined in terms of log reduction and inactivation percentage. 
The optimal inactivation of spore was determined at 35 MPa, 75˚C in 90 min which 
showed the predicted and experimental reductions as 5.93 and 6 log, respectively 
with 99.9999% of inactivation. It was also found that after treatment the samples by 
SC-CO2, no regrowth was observed. At the optimal condition of SC-CO2, the spores 
of the most common fungal species were completely inactivated (6 log reduction). 
The attractions of the inactivated fungal spores were examined using SEM analysis 
which revealed that after SC-CO2 treatment, the cell wall of fungal spore was 
completely damaged (burst) and deformed as compared to steam autoclaved and 
untreated ones. The plate assay study revealed that the inactivated fungi spores did 
not produce any extracellular enzyme. In conclusion, clinical wastes have high 
contents of opportunistic fungi, which might cause several diseases in human being. 
This study significant in proving that SC-CO2 as an advanced non thermal method is 
capable in inactivating fungal species found in clinical wastes, hence reducing the 
health risks during the handling of these clinical waste thus making it safer.  
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CHAPTER ONE 
 INTRODUCTION 
1.1 Fungi and clinical wastes  
Fungi are eukaryotic organisms including yeasts and moulds. These organisms 
are classified in separate kingdom called Fungi. Yeasts are unicellular and reproduce 
by budding process. Moulds are multicellular filamentous organisms belong to the 
fungi group. The reproductions of filamentous fungi are by sexual and asexual spores.  
Fungi cause several serious diseases in humans, animals and plants. However, the 
opportunistic fungi, which are also called invasive fungal infections, are the most 
important for human health (van Burik and Magee 2001). The prevalence of fungal 
infections caused by opportunistic fungi has increased since the 1990s due to an 
intensive immunosuppressive chemotherapy, increasing of immune-compromised 
patients and the widespread use of broad-spectrum antibiotics (Beck-Sague and Jarvis 
1993).   
The expansions of communities and cities in the last two decades have led to 
an equal increase in the number of healthcare facilities and clinical wastes generated 
from these facilities. The amount of clinical wastes generated form healthcare facilities 
in Malaysia increased from 3,303 to 18,055 tonnes per year from 1997 to 2012. In 
2012, there were 398 hospitals with 56,872 beds, thousands of clinics and hundreds of 
diagnostic, research and haemodialysis centres (Department of Statistics 2013a). The 
amount of clinical wastes generated from healthcare facilities expected to be 33,000 
tonnes per year by 2020 due to the increasing of population and thus health 
establishments (Ambali et al. 2013). 
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Clinical wastes are defined as any waste containing blood or human body fluids 
generated from hospitals, medical centres, clinics, pharmaceutical or other related 
clinical activity. In general any wastes generated from healthcare facilities are 
managed as clinical wastes and represent a potential source of infection (WHO 2005). 
In Malaysia, Environmental Quality ACT 1974, Scheduled Wastes (Regulations 2009) 
has defined the clinical wastes in the following categories; pathogenic and clinical 
wastes generated from pathological Sections of hospitals, expired drugs containing 
toxic, harmful, carcinogenic or mutagenic (EQA 1974, 2011). 
1.2 Risk caused by fungi in clinical wastes 
Clinical wastes are considered one of the most important sources for the 
infection of human being due to the existence pathogenic microorganisms such as 
bacteria, virus and fungi (Saini et al. 2004; Park et al. 2009). However, fungi represent 
more importance than bacteria, since they could grow and multiply in clinical wastes 
without any intermediates as hosts. These characteristics are common in some bacteria. 
Moreover, fungi can grow at low levels of water activity (aw) compared to bacteria 
(0.60-0.85 vs. 0.89-0.97 respectively). Another reason is fungi spread their external 
spores to the environment which has become harmful for human health (Jay 2000; 
Deacon 2005; Grant et al. 1989; Nielsen et al. 1999; WHO 2009).   
The presence of fungi in the clinical wastes and environment has been reported 
by many investigators around the world. Neely and Orloff (2001) isolated Fusarium 
sp., Mucor sp., Paecilomyces sp., Aspergillus sp. from clinical wastes in USA. Vieira 
et al. (2010) identified Alternaria sp., Aspergillus spp., Aureobasidium sp., 
Basipetospora spp., Cladosporium spp., Curvularia spp., Fusarium spp., Penicillium 
spp., Scopulariopsis spp., and Scytalidium sp. in the dental healthcare facilities in 
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Brazil. Şahil and Otag (2013) recovered Aspergillus spp., Acremonium spp., Alternaria 
spp., Cladosporium spp. and Fusarium spp., from the clinical wastes in Turkey and 
revealed that these fungi survived for one year in the clinical wastes discharged into 
the environment.  
In Malaysia, few studies have been conducted on the inventory of fungi in the 
wastes. A. niger, A. fumigatus, Candida sp., Fusarium sp., Mucor sp., P. 
chrysosporium and T. harzianum have been detected in palm oil mill effluents (POME) 
wastes (Kabashi et al 2006; Soleimaninanadegani and Manshad 2014; Bala et al. 
2015). Cryptococcus neoformans, Candida spp. and Pencillium marneffei have been 
detected as the most common IFIs among the patients in Malaysia (Tamring et al. 
2014). Abdul-Rahman et al. (2008) have indicated that Candida spp. were the most 
predominant in the genital, urine and blood culture specimens. However, these studies 
have not investigate those species in the disposed clinical wastes.    
1.3 Treatment of clinical wastes 
The clinical wastes have less organic contents compared to that in domestic 
refuse. However, the clinical wastes are responsible for more than 60% of the costs of 
the treatment processes by incinerations (Blenkharn 2005). In Malaysia, incineration 
is the main method of clinical wastes treatment. There are three main companies in the 
country for the handling and treatment of clinical wastes. These are Faber Medi-Serve 
Sdn Bhd (Perlis, Kedah, Penang, Perak, Sabah and Sarawak), Pantai Medivest Sdn 
Bhd (Negeri Sembilan, Melaka and Johor) and Radicare (M) Sdn Bhd (Wilayah 
Persekutuan Kuala Lumpur and Putrajaya, Selangor, Pahang, Kelantan and 
Terengganu) (Chuah et al. 2009; Khanehzaei et al. 2014). These companies collect the 
clinical wastes from the large hospitals daily in yellow containers, while smaller 
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hospitals that produce lesser amount of clinical wastes, the wastes are stored at -1 to -
5˚C until collection every 3 days.  
Several of the alternatives technologies have been suggested for the treatment 
of clinical wastes. These technologies including autoclave, irradiation, microwave and 
chemical disinfection were effective for inactivation of pathogenic organisms and have 
achieved 6 log reductions (U.S. EPA 1990; Salkin 2003; Lee et al. 2004; Da Silva et 
al. 2005; STAATT 2005; Shinee et al. 2008; Bendjoudi et al. 2009; Abd El-Salam 
2010; Hossain et al. 2012). 
The chemical disinfection and irradiations treatments of the clinical wastes are 
unable to completely damage of pathogens. Thus, the treated clinical wastes still 
contains heavily load of infectious agents due to weaknesses and disadvantages of 
these techniques (Tsakona et al. 2007; Nemathaga et al. 2008). Furthermore, these 
technologies create health hazard and environmental pollution rather than reducing 
infectious risk in the waste. This gap offered investigators a greater opportunity to 
explore the alternative technology is effective for the clinical wastes treatment and 
eco-friendly and this is the focus of this study. 
The inactivation of yeast and moulds using SC-CO2 in normal saline, distilled 
water, grape juice, barley grains and growth medium revealed that SC-CO2 has 
significant capability to inactivation  Saccharomyces cerevisiae, A. niger, A. 
ochraceus, P. oxalicum by 6 log reductions (Nakamura et al. 1994; Shimoda et al. 
2002; Gunes et al. 2005; Park et al. 2013; Neagu et al. 2014). SC-CO2 has found as an 
efficient tool for the sterilization of food and inactivating of microorganisms without 
any destruction of the nutritional contents (Balaban et al. 2001; Gunes et al. 2005). It 
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may be due to that SC-CO2 depends on the diffusion of pressured CO2 through the cell 
membrane of microorganism and not on temperature like autoclave (Zhang et al. 
2006b). This characteristic makes SC-CO2 advance compared to incineration, 
microwave and autoclave technologies for treating clinical wastes especially 
recyclable and reusable wastes.  
1.4 Problem statement  
Many fungi can be found in hospitals and other clinical facilities or 
laboratories, which form a composite in the wastes, generated from these premises.  
The clinical wastes present an appropriate and fertile environment for the reproduction 
of fungi due to the right temperature and proper nutrients as well as the adequate 
moisture and pH of the clinical wastes is favourable for their growth (U.S. EPA 1990). 
The fungal diversity in the clinical wastes have been investigated worldwide. In 
Malaysia, few information about the fungal contents in the clinical wastes is available. 
It was may be due to the fact that the amount of clinical wastes represent less than 3% 
of the total wastes (DS 2013a). Nevertheless, the importance of clinical wastes as one 
of the main sources for infectious agents warrants the needs to understand the fungal 
load in these wastes to facility choice the suitable treatment process and then protect 
human health. In the current study, the identification for the fungal inventory in the 
clinical wastes has investigated and this emphasizes the originality of the study.  
The clinical wastes are treated by using incinerator, which convert it to ash and 
then dispose into landfill (Razali and Ishak 2010). However, incineration is not a 
suitable technology for the treatment of clinical wastes due to the inevitable production 
of hazardous pollutants including dioxins and furans (Blenkharn 2005; Coker et al. 
2009; Ambali et al. 2013). This provides strong support for a move away from costly 
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destruction of clinical wastes by incineration. The new trends is to find a non-thermal 
technology of clinical wastes avoids the toxic by-products generated from utilization 
of the conventional technologies. As SC-CO2 depends on the solubility and diffusion 
of pressure through the cell membrane of microorganism, it has an effective for the 
inactivation of microorganisms (Zhang et al. 2006a). SC-CO2 is also nontoxic, 
inflammable and eco-friendly thus, has not negative effects on the human and 
environment compared to thermal or chemical treatments (Spilimbergo et al. 2002).  
The efficiency of SC-CO2 for inactivating of pathogenic bacteria in clinical 
wastes has been investigated which indicated that SC-CO2 has inactivated S. aureus 
and P. aeruginosa by 6 log reductions and met the standards limits for level I 
recommended by STAATT (Banana 2013; Hossain 2013). However, up to date no 
study was reported regarding the inactivation of fungi in clinical waste samples. 
Therefore, this research focussed on the effectiveness of the SC-CO2 to inactivate fungi 
found in clinical wastes and sought to prove if SC-CO2 has the potential to be the initial 
step in treating the clinical wastes within the clinical premises.  
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1.5 Objectives 
The general objective of present study is to explore the fungal contents in the 
clinical wastes. The present study focuses in the particularly to achieve the following 
aims: 
1. To  identify the fungal species recovered from the clinical waste samples based 
on phenotypic methods  
2. To determine the efficiency of SC-CO2 in the inactivation of the common fungal 
spores in clinical waste in comparison with steam autoclave.    
3. To identify alterations on the morphology of SC-CO2 treated spores and 
production of extracellular enzymes  
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1.6 Significance and scope of the study 
The clinical wastes represent 3% of the total wastes in Malaysia. However, 
these wastes have high contents of pathogenic microorganisms. Therefore, raises the 
need to understand role of the clinical wastes as infectious agents for human and 
environment. It has been suggested that in order to minimize the amount of clinical 
wastes with inherent infectious risk, clinical waste management should incorporate 
waste minimization and additional segregation of wastes at source. Such initiatives can 
vastly reduce the volumes of clinical wastes sent for disposal; significant cost savings 
may accrue. Nonetheless, this does not circumvent the infectious nature and the risks 
borne by clinical wastes. In order to handle the infectious nature inherent in these 
pathogen contaminated wastes, proper inactivation treatment is deemed to be of great 
urgency. This study is one of the few studies if not the first study which addressed the 
fungal inventory of the clinical wastes and the inactivation of the fungi in these wastes 
in Malaysia. 
The present study demonstrated that the high content of fungi in clinical wastes 
is a clear indicator for the biohazards of these wastes and the need to be treated before 
the final discharge into the environment. The identification of the fungal isolates was 
conducted using phenotypic method to study the similarity and differences between 
fungal species within each genus.   The fungal content of clinical wastes depended of 
the type and generation source of these wastes indicating the role the segregation 
process of these wastes in the management of the clinical wastes. . The study revealed 
that the storage condition play an important role for the distribution of fungal spores 
into the air and suggested the storage of clinical should be less than 24 hrs before the 
final treatment to minimize the distribution of fungal spores into the surrounded 
environment.  
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The results in the current work confirmed the usefulness of SC-CO2 as non-
thermal alternative for safe handling of the clinical wastes. Besides avoiding the 
adverse effects of the incineration, the present treatment showed more advantages 
since this technique would be used for the raw clinical wastes without chemical 
additive as recommended by STAATT (2005) or primary treatment was required.  
As, the fungal spore might be regrow after the inactivation processes, the 
inactivated spores were recovered on enriched medium (V8 agar) and moderately 
enriched medium (PDA) and incubated at the optimal condition for fungal growth 
(28˚C) for 10 days. No fungal growth was observed which indicated that the fungal 
spores have died and not only inactivated. Besides, since the fungal spores might 
produce cellulase and protease enzyme without germination, the bioassay for these 
enzyme and others (lipase and amylase) was assessed using plate assay technique. No 
enzyme production by inactivation spores was recorded compared to control 
(untreated) which has produced datable amount of these enzymes. These results 
confirmed that the fungal spores were dead. Then, as the fungal spore might be in an 
available but non-culturable state (VBNC) the integrity of cell wall and cell membrane 
was observed using SEM. The spore shape was completely damaged, cell wall and cell 
membrane was totally destroyed. These observations proved that the fungal cytoplasm 
was extracted and demonstrate that the spores have irreversible lost the ability to 
regrow even at the optimal conditions for fungal growth.  
Finally, the irreversible loss of fungal growth is an evidence for the safe 
disposal of the clinical wastes, where the fungal spores would not represent any 
hazards on the human and environment.   
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CHAPTER TWO 
LITERATURE REVIEW 
2.1 Introduction  
The selection an appropriate technology in the treatment of clinical wastes is 
crucial due to potential health risk associated with these wastes. Clinical wastes 
contain heavily loads of pathogenic microorganisms. The importance of these 
pathogens lie in their ability to cause severe diseases for human because they have 
already adopted with the human body as well as these pathogens have acquired 
resistance for several antibiotics that were used during the treatment process of the 
patients. Indeed, the pathogenic microorganisms in clinical wastes are same to that in 
the patient specimens; the clinical specimen is defined as a clinical waste just after the 
examination process in the diagnostic laboratories and dispose to the wastes basket.  
The most common technologies applied for the sterilization or treatment of 
clinical wastes are the incineration, autoclave, irradiation and microwave. Moreover, 
the adverse environmental impact of these technologies which include the toxic by-
products and detrimental effects on the human and environment have been extensively 
documented. Currently, the new trend is to use non-thermal sterilization technologies. 
Supercritical carbon dioxide (SC-CO2) is one of these technologies because it is 
depend on the pressure and low temperature. It exhibited efficiency for inactivation of 
fungi in food and pharmaceutical products. The studies conducted on inactivation of 
pathogenic bacteria in clinical wastes have revealed that SC-CO2 is effective for 
reduction of pathogenic bacteria; clinical wastes treated by SC-CO2 have met the 
standards limits recommended by STAATT (2005) for safe disposal. Therefore, it is 
time to investigate SC-CO2 as a non-thermal alternative technology for inactivation of 
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fungi in clinical wastes in order to safe handling and thus minimize the exposure for 
fungal spores associated with these wastes. In this chapter the fungal load of clinical 
wastes and the potential using SC-CO2 for the inactivation of fungal spores in clinical 
wastes are viewed based on understand the inactivation mechanism of SC-CO2 against 
fungi and bacteria that has been described by authors during the last years (Nakamura 
et al. 1994; Shimoda et al. 2002; Gunes et al. 2005; Park et al. 2013; Neagu et al. 2014).    
2.2 Characteristics of fungi 
Fungi are eukaryotic organisms, which are composed of filaments 
called hyphae. Hyphae may contain internal cross walls, called septa. A mass of 
hyphae that is not a reproductive structure is called a mycelium. Hyphae represent the 
vegetative part of fungi, which contains nucleus, mitochondrion, ribosomes and all 
metabolic pathways of fungal cell. The hypha is surrounded by cell wall that protects 
fungus cell from changes in osmotic pressure and other environmental stresses. The 
cell wall is composed of macromolecules (chitosan, chitin, lipid, glucan, 
phospholipides), which contain amino, carboxyl, melanin, phosphate, hydroxides and 
sulphates groups (Fogarty and Tobin 1996; Bowman and Free 2006; Hardison and 
Brown 2012).  
Fungi are typically non-motile, heterotrophic organisms and have quite simple 
nutritional requirements. Most of fungi are saprophytic organism which get the 
nutrient by breaking down dead organic material using hydrolysis enzymes such as 
lipase, cellulase, amylase and protease. Others are pathogenic for human such as 
Blastomyces, Histoplasma, Coccidioides and Paracoccidioide that named dimorphic 
or ‘endemic’ fungi, which grow as filamentous form at 25˚C and as yeasts form or 
spherules in host tissue when are incubated at 35˚C. Some of fungi are opportunistic 
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organisms that have a potential to cause secondary infection for human (Deacon 2005; 
Şahil and Otag 2013). 
The fungi reproduce sexually and asexually, but the majority of fungi have 
asexually reproduction. Therefore, fungi represent a supreme example of spore-
producing organisms (Deacon 2005). In asexual multiplication, the fungi produce 
conidia (spores) that are mounted on conidiophore. The spores are distributed into the 
environment and germinate to fungal mycelium.  
The identification of fungi is performed using phenotypic and molecular 
techniques. In the phenotypic method, the identification depends on the culture and 
microscopic characteristics of the fungi, the diversity of the fungal conidiophores and 
spores in the shape and size are usefulness for the morphological identification of fungi 
(Kumara and Rawal 2008; Emine et al. 2010). In contrast with bacteria, fungi have 
high diversity in their microscopic morphology such as conidiophore and spores, these 
microscopic characteristics are useful to identify some of fungal isolates such 
Aspergillus sp. Penicillium sp., Trichoderma sp. Curvularia sp. and Rhizopus sp. to 
species level. In Aspergillus spp. the structure of conidiophore is very important for 
their identification (Robert et al. 2011; Silva et al. 2011). The conidiophores are 
originated from the mycelium, and terminate in a vesicle. The conidiophores structures 
depend on the fungal species (Figure 2.1 a,b).  
13 
 
  
 
Figure 2.1 Conidiophore structure of fungi; A) Aspergillus spp. B) Penicillium spp. 
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The phialids (spore producing cells) which are located on the vesicle is also an 
important character for the identification. The phialids may be radiate head where they 
cover the entire vesicle surface or columnar head where they cover the vesicle surface 
partially. The phialids are attached to the vesicle directly (uniseriate) or via metula 
(biseriate) (Jensen et al. 2013).The spore shape and size as well as spore surface 
ornamentations also represent an important key for the phenotypic identification 
(Figure 2.2). 
 
 
Figure 2.2 Fungal spores shape (CTR 2014) 
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The developments in the Scanning Electronic Microscopy (SEM), Fluorescent 
Microscopy and Flow Cytometry have enhanced the recognition of fine details of 
phenotypic taxonomic significance (Cole and Samson 1979; Guarro et al. 1999). The 
SEM has the ability to show the slight differences in the spore structure for classifying 
the fungal isolate to the varieties level. For instance, C. lunata has two varieties: C. 
lunata var. aeria with smooth conidia and stromata in culture; and C. lunata var. lunata 
with smooth to roughly conidia but without stromata in culture (Ellis 1971; Sivanesan 
1987). These varieties are identified as C. lunata and C. aeria based on molecular 
analysis (Nakada et al. 1994; Cunha et al. 2013).  
2.3 Clinical wastes in Malaysia   
Clinical wastes are generally health wastes that are hazardous and represent a 
potential source of human infection. EPA (2009) identified the clinical wastes as any 
wastes contaminated with blood or human body fluids and generated from healthcare 
facilities during the treatment of patients or during research projects. The healthcare 
facilities include medical, dental, nursing, diagnostic laboratory, podiatry, 
pharmaceutical, tattooing, emergency, body piercing, services and blood banks. 
According to WHO (2005), human anatomical wastes, pathological wastes, diagnostic 
laboratory wastes, sharps, medicines and cytotoxic drugs, disposable solid wastes and 
liquid wastes (blood and body fluids) as well as chemical wastes could be classified as 
clinical wastes. The various types of clinical wastes are presented in Figure 2.3.  
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Figure 2.3 Clinical wastes generated from the healthcare facilities  
 
 
 
 
 
 
Clinical wastes generated from patient room and clinics 
Human body parts, blood, catheters, 
excised tumor, surgical dressing and 
spandex, pathological wastes 
Pharmaceutical wastes, 
ampules, expired drugs 
and fluids   
Sharps, cotton, gloves, mask, 
blades, fluids nutrition, swaps, 
tissue papers   
P
h
ar
m
ac
ie
s 
d
ru
g
s 
st
o
re
  
Pharmaceutical 
wastes, expired 
drugs and fluids   
 R
ad
io
lo
g
y
 c
li
n
ic
s 
 
Radioactive 
substances 
 
Clinical wastes generated from Diagnostic laboratories  
Blood waste, urine, pus, saliva, 
sputum, CSF, vaginal scraping, 
respiratory secretion, stool, biopsy, 
body part    
 
Lab cultures, yellow and 
blue tips, broken gasses, 
scalps  
 
Sharps, tissue papers, cotton, 
gauzes, swaps, blades  
CLINICAL 
WASTES 
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The amount of clinical wastes generated from healthcare facilities have been 
increased during the recent years. Clinical wastes represent 12.5-69.3% of the total 
healthcare wastes, among them 10-25% are high-risk wastes (WHO 2005; 
Visvanathan 2006; Nemathaga et al. 2008; Shinee et al. 2008). WHO (2000) has 
estimated the quantities of clinical wastes generated from healthcare facilities to be 
between 0.5-3 kg/bed/day. In Malaysia, the average of healthcare waste generation is 
1.9 kg/bed/day (Visvanathan 2006).  This value is less than reported in North and 
South America and Western Europe, but higher than that estimated in Pakistan, 
Thailand, India and China (Figure 2.4). The variance found among these countries are 
a result of different level of economic strength and healthcare facilities, size and type 
of the medical institution and number of patient care (Johannessen 1997; WHO 2005; 
Da Silva et al. 2005; Visvanathan 2006; Marinkovic et al. 2008; Nemathaga et al. 
2008; Cheng et al. 2009; Ruoyan et al. 2010). 
As presented in Figure 2.4, it can be noted that the rate of clinical wastes 
generated from healthcare establishments depends on the level of developments of the 
country. Developed countries generate more clinical wastes at a higher rate than that 
of developing countries (Pruss et al. 1999). According to Halbwachs (1994), the 
health-care wastes generated from high-income countries ranged between 1.1 and 12.0 
kg/person, while low-income countries produce between 0.5 and 3.0 kg/person. 
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Figure 2.4 Estimated average healthcare waste generation in different region in the world 
(WHO 2005; Visvanathan 2006; Johannessen 1997; Da Silva et al. 2005; Cheng et al. 
2009; Ruoyan et al. 2010). 
The quantities of clinical wastes handled for the destruction by incineration in 
Malaysia during the period from 2006 to 2012 are shown in Figure 2.5. It was indicated 
that the quantities of these wastes increased by 37.1 %.   
 
 
Figure 2.5 Quantity of clinical waste handled for destruction at incinerator Malaysia. Source; 
Department of Environment (Department of Statistics 2011, 2013a)  
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In 2012, Malaysia had more than 398 hospitals (147 public and 251 private 
hospitals) with 42707 vs. 14165 beds for public and private hospitals, respectively (DS 
2013a). Based on the daily amount of clinical wastes generated in Malaysia (1.9 
kg/bed/day), the estimated quantities of clinical wastes generated from public hospitals 
in 2012 were 29,617.546 tonnes/year. However, Department of Statistics in Malaysia 
(2013a) reported that only 18,055 tons have handled for destruction by incinerator 
(distributed for each state as depicted in Figure 2.6). It was due to that the maximum 
loading capacity for incinerators in Malaysia are 18,000 tons/year (Frost and Sullivan 
2010).   
 
Figure 2.6 Quantity of clinical waste handled for destruction at incinerators by state, Malaysia, 
Source; Department of Environment (Department of Statistics 2013a)  
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wastes (Alagoz and Kocasoy 2008; Marinkovic et al. 2008; Park et al. 2009; Wiafe et 
al. 2015; Khazaee et al. 2015). Several countries have adopted the regulations for the 
proper management of clinical wastes. In the UK, the Department of Health (2013) 
has published the guidelines for the management of healthcare waste. In the USA, EPA 
(2009) has regulated the organization of clinical wastes, including the storage, 
transport, treatment and disposal processes. In Australia, the legislation for collection, 
segregation and treatment of clinical waste has been in practice since the 1990s by the 
Ministry of Health (1998). In Turkey, the Ministry of Environment and Forestry 
(MEF), controls the management of healthcare wastes since 1993; the legislation 
includes the procedures for segregation, collection, transportation, storage of clinical 
wastes and the transportation to the final disposal area (MEF 2005). 
In Malaysia, the regulations for clinical wastes management have started in 
1989 (Razali and Ishak 2010; Ambali et al. 2013). These regulations are described in 
more detail in a new version of Environmental Quality ACT 1974, Scheduled Wastes, 
Regulations 2009 (EQA 1974, 2011). Three concession companies have been 
appointed by the government to handle and treat clinical wastes generated in public 
hospitals in Malaysia (Chuah et al. 2009), which use incineration for the final treatment 
of the clinical wastes; however, with increasing quantities of wastes, the needs for 
more incinerators to treat clinical wastes has also increased. In contrast, among the 150 
incinerators constructed in New York State, USA, in 1990, 142 have been closed by 
2000 due to the negative impacts on human health and the environment (Banana 2013). 
Consequently, it is imperative that alternative technologies for treatment of 
clinical wastes, especially non-thermal sterilization technologies, be sought. In the last 
years, alternative technologies for treatment of clinical wastes have been ventured; for 
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instance, thermal treatment (microwaving, moist and dry heat, laser, infrared, plasma, 
gasification and pyrolysis), chemical disinfection (chlorination, ozonation, hydrogen 
peroxide and sodium hydroxide) and irradiation treatment (UV, Cobalt 60, electron 
beam) (STAATT 2005). In Malaysia, these technologies have not been applied at a 
large scale yet, and autoclaves are used in numerous hospitals as a primary treatment, 
while incineration is used as final treatment. Few studies have been conducted on the 
treatment of clinical wastes by autoclave, microwave and supercritical carbon dioxide 
at laboratory scale, which show the potential in applying these techniques at full scale 
(Banana 2013; Hossain 2013). However, these studies focused only on pathogenic 
bacteria, whereas clinical wastes contain several other pathogenic organisms including 
fungi and viruses. Therefore, more studies are necessary to accurate evaluate these 
techniques before full-scale application. In the United States, steam autoclave is used 
for treatment of clinical wastes, whereby there are more than 100 commercial 
autoclave plants for processing infectious waste (Hossain et al. 2011).  
2.4 Health risks of clinical waste 
Information regarding the microorganism presence in wastes generated by 
healthcare facilities can shed light on the level of serious potential of harm to the public 
and the environment (Sherman 2007). This is certainly critical and regulations imposed 
by countries consider this matter. The abatement of the risks has often been placed 
within the management as in the effective waste segregation or minimization of 
clinical waste that may reduce the biohazards risk of these wastes. The risks that are 
associated with the presence of microorganisms must, however, focus on the 
inactivation of these pathogens as soon as the wastes are generated. Effective clinical 
waste segregation or minimization may reduce the biohazards risk of these wastes, 
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however, the infectious agents to healthcare worker are still possible because of the 
infectious nature for these wastes. The health risk of clinical wastes that needs to be 
assessed is the presence of pathogenic microorganisms. As Park et al. (2009) aptly 
pointed out, infectious threat to healthcare worker is still possible because of the 
presence of the infectious pathogens in these wastes. Park et al. (2009) identified 
various types of pathogens, bacteria and fungi that are most commonly considered as 
health risks due to the ability of these organisms to multiply and persist for a long time 
in clinical wastes, while viruses cannot survive in clinical wastes without a host 
organism. The argument is congruent to Hall (1989) and Saini et al. (2004), who 
stressed that the environmental factors of clinical wastes such as presence of carbon 
and nitrogen source (sugars, protein, starch, fats and other compounds), and growth 
factors are suitable for growth and survival of bacteria and fungi. In the next section, 
the presence of bacteria and fungi in the clinical waste is reviewed.  
2.4.1 Fungi in clinical wastes 
The importance of fungi as infectious agents is well recognized worldwide. 
Fungi cause several serious diseases for human, of particular concern is the 
opportunistic pathogens including Alternaria spp., Aspergillus spp., Cryptococcus  
neoformans, Candida spp., Fusarium spp., Mucorales, Paecilomyces spp., and 
Scedosporium spp. which also called invasive fungal infections (IFIs) (Beck-Sague 
and Jarvis 1993; Sifuentes-Osornio et al. 2012; Tamring et al. 2014).   
In Malaysia, Cryptococcus neoformans, Candida spp. and Pencillium 
marneffei are the most common species as IFIs. A. niger, Curvularia spp., Fusarium 
spp. and P. lilacinus have also detected in the laboratory diagnostic process (Tamring 
et al. 2014). Abdul-Rahman et al. (2008) have studied the distribution of Candida spp. 
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from 3837 clinical specimens in Hospital of USM during the period from 2001 to 2006. 
The study revealed that Candida spp. were predominant in genital specimens, urine 
specimens and blood culture specimens. 
Aspergillus spp. are ubiquitous fungi and natural inhabitants of soil, water and 
organic vegetation and debris (Ryan 2004). The spores of Aspergillus spp. have the 
ability to survive for a long time in the environment and they have been isolated from 
dust produced during the course of hospital renovation (Araujo et al. 2006). 
Aspergillus can cause many diseases for human, A. fumigatus, A. flavus, A. terreus, A. 
niger and A. nidulans are the most common (Hogan et al. 1996; Macêdo et al. 2009; 
Şahil and Otag 2013). Invasive aspergillosis (IA) is the second most common cause of 
nosocomial fungal infections (Segal 2009). It has detected in 57.6% of immune-
compromised patients (Pagano et al. 2011).  
Penicillium spp. are the most common fungi in the environment, they have low 
pathogenicity for humans. However, in immune-compromised patients they can be 
virulent pathogens and can cause death (Oshikata et al. 2013). Penicillium marneffei 
has been recorded as the third most common opportunistic fungi among patients 
infected with human immunodeficiency virus in certain parts of Southeast Asia, India, 
and China (Duong 1996; Vanittanakom et al. 2006). Barcus et al. (2005) reported an 
intestinal invasion and disseminated disease associated with Penicillium chrysogenum 
in USA. P. digitatum has detected as infectious agent for human and caused the fatal 
pneumonia infection in Brazil (Oshikata et al. 2013). 
The presence of fungi in the diagnostic specimens, lab cultures and others 
healthcare facilities are suspected to be associated with the contamination in clinical 
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wastes. Few studies have been published on the presence of fungi in clinical wastes, 
but these studies have revealed a wide range of fungi in clinical wastes. Neely and 
Orloff (2001) investigated survival of Aspergillus spp., Fusarium sp., a Mucor sp., and 
Paecilomyces sp. in hospital fabrics and plastics such as cotton, terry, blend, polyester, 
spandex, polyethylene and polyurethane in USA. A. flavus, A. niger, A. fumigatus and 
A. terreus can be lived more than 30 days on cotton, blend, polyster, polyethylene and 
polyurethane. Fusarium sp. survived for 10 days on cotton, blend, spandex and 
polyester and for more than 30 days on polyethylene, Mucar sp. persisted more than 
20 days on all types of hospital fabrics and plastics except of terry (16 days), the 
maximum survival of Paecilomyces sp. has noted on spandex and polyurethane (11 
days). Fungi also have the ability to live in the clinical wastes disposed into landfill, 
Oyeleke and Istifanus (2009) have studied the presence of fungi in the 24 hospital 
waste samples taken from different hospitals waste dumpsites and its surrounding soil 
in Nigeria. The isolated fungi included A. niger (34.48 vs. 44.44%), A. flavus (13.79 
vs. 3.70%), A. parasiticus (0 vs. 7.41%), A. versicolor (3.45 vs. 3.45%), A. nidulans (0 
vs.11.11%), Penicillium rubrum (6.86 vs. 3.70%), Trichoderma roseum (0 vs. 3.70%), 
P. viricadum (6.90 vs. 0%), Rhizopus nigricans (27.59 vs. 18.52%) and Microsporum 
canis (6.9 vs. 0%).   
Fungi are saprophytic in origin, they produce external spores, which spread to 
air. Therefore, even if the clinical wastes generated from different sections of 
healthcare facilities are free from fungi. These wastes may expose to the fungal 
contamination during the storage period. It was due to the conditions of storage such 
as temperature, nutrients, moisture, pH are favourable for their growth (U.S. EPA 
1990). The presence of airborne fungi in healthcare facilities has been reported. Vieira 
et al. (2010) evaluated airborne fungi in the Brazilian dental healthcare environment 
